Bolt Biotherapeutics Inc.
BOLT | NASDAQ
$3.59
+$0.03 (+0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$3.59
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Market Data
Market Cap $6.84M
Enterprise Value $10.92M
Beta 1.09
Average Volume 24.45K
Shares Outstanding (Diluted) 1.69M
Shares Change YoY -11.84%
Institutional Ownership 32.80%
Exchange NASDAQ
ISIN US0977022039
Price Performance
Price Change 1M -1.6%
Price Change 3M -15.7%
Price Change 6M -20.2%
Price Change YTD -38.0%
Price Change 1Y -32.8%
Price Change 3Y -82.7%
Price Change 5Y -98.6%
1M CAGR (ann.) -8.0%
1Y CAGR (ann.) -33.7%
5Y CAGR (ann.) -59.7%
All-Time CAGR -60.3%
Valuation
PE Ratio -0.22
Forward PE N/A
PEG Ratio 0.00
Forward PEG -0.02
PS Ratio 1.47
Forward PS 2.00
PB Ratio 0.55
P/FCF Ratio -0.22
P/Adj. FCF Ratio -0.20
P/OCF Ratio -0.19
EV/Sales 2.32
EV/EBIT -0.38
EV/EBITDA -0.39
EV/FCF -0.35
Earnings Yield -445.7%
FCF Yield -457.1%
Adj. FCF Yield -494.0%
Financial Health
Net Cash $17.6M
Total Debt $21.62M
Cash & Short-Term Investments $17.6M
Total Assets $40.34M
Current Ratio 2.61
Quick Ratio 2.61
Debt / Equity Ratio 1.71
Debt / EBITDA -0.78
Debt / FCF -0.69
OCF / Debt -1.45
Interest Coverage 0.00
Altman Z-Score -18.22
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 95.7%
Operating Profit Margin -623.0%
EBITDA Margin -591.9%
Net Profit Margin -611.5%
FCF Margin -671.0%
Adj. FCF Margin -725.1%
SBC / Revenue 54.1%
SBC Impact (per share) -8.1%
Returns
Return on Assets -71.2%
Return on Equity -126.2%
Return on Invested Capital -82.3%
Return on Capital Employed -90.2%
Return on Tangible Assets -71.2%
Historical Growth (CAGR)
Revenue CAGR 3Y -11.5%
Revenue CAGR 5Y -0.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -91.8%
EPS CAGR 5Y -54.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y 33.2%
FCF CAGR 5Y 20.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 8
EPS Growth Next 3Y -40.7%
Revenue Growth Next 3Y 19.4%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$3.89
EPS Growth Est (next Q) 4.6%
Revenue Est (next Q) $68.33K
Revenue Growth Est (next Q) -96.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4
Price Target Upside 11.4%
Cash Flow
Operating Cash Flow $-31.45M
Free Cash Flow $-31.54M
Adj. Free Cash Flow $-34.08M
FCF Per Share -$18.65
OCF Per Share -$18.60
OCF/S Ratio -669.2%
Income Statement
Revenue $4.7M
Gross Profit $4.5M
Operating Income $-29.28M
EBITDA $-27.82M
Net Income $-28.74M
EPS (Diluted) -$16
Revenue / Employee $204.35K
Profit / Employee $-1.25M
Employees 23
Add to Watchlist
Select watchlists to add or remove BOLT